Clinical Trial Update: PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetics trial evaluating the PROMUS Element stent system for de novo coronary artery lesions has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PROMUS Element Stent System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-04-05